CY1117505T1 - SUPPLEMENTARY BATTERY ADMINISTRATION AND FACTORS AGAINST CY C5 USEFUL IN EDUCATION AGAINST EYE DISEASES - Google Patents
SUPPLEMENTARY BATTERY ADMINISTRATION AND FACTORS AGAINST CY C5 USEFUL IN EDUCATION AGAINST EYE DISEASESInfo
- Publication number
- CY1117505T1 CY1117505T1 CY20161100203T CY161100203T CY1117505T1 CY 1117505 T1 CY1117505 T1 CY 1117505T1 CY 20161100203 T CY20161100203 T CY 20161100203T CY 161100203 T CY161100203 T CY 161100203T CY 1117505 T1 CY1117505 T1 CY 1117505T1
- Authority
- CY
- Cyprus
- Prior art keywords
- useful
- education
- eye diseases
- factors
- supplementary battery
- Prior art date
Links
Abstract
Μέθοδοι αγωγής έναντι οφθαλμικών διαταραχών που διαμεσολαβούνται από το συμπλήρωμα και που ενέχουν χορήγηση παραγόντων οι οποίοι αναστέλλουν ένα συστατικό του συμπληρώματος ενός ατόμου υπό ποσό επαρκές προς αγωγή έναντι της οφθαλμικής διαταραχής όπου, σε μία επιλεγμένη υλοποίηση, ο αναφερθείς παράγοντας είναι ένα απταμερές έναντι του συμπληρώματος το οποίο, σε μία προτιμούμενη υλοποίηση, είναι ένα απταμερές έναντι του C5.Methods of treatment for complement-mediated ocular disorders involving administration of agents which inhibit a component of a person's complement in an amount sufficient to treat ocular disorder where, in a selected embodiment, the agent is which, in a preferred embodiment, is an apatomere with respect to C5.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78090506A | 2006-03-08 | 2006-03-08 | |
US84827406A | 2006-09-29 | 2006-09-29 | |
EP12173138.4A EP2596807B1 (en) | 2006-03-08 | 2007-03-08 | Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1117505T1 true CY1117505T1 (en) | 2017-04-26 |
Family
ID=58457110
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151100047T CY1115965T1 (en) | 2006-03-08 | 2015-01-16 | SUPPLEMENTARY BATTERY ADMINISTRATION AND FACTORS AGAINST CY C5 USEFUL IN EDUCATION AGAINST EYE DISEASES |
CY20161100203T CY1117505T1 (en) | 2006-03-08 | 2016-03-08 | SUPPLEMENTARY BATTERY ADMINISTRATION AND FACTORS AGAINST CY C5 USEFUL IN EDUCATION AGAINST EYE DISEASES |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151100047T CY1115965T1 (en) | 2006-03-08 | 2015-01-16 | SUPPLEMENTARY BATTERY ADMINISTRATION AND FACTORS AGAINST CY C5 USEFUL IN EDUCATION AGAINST EYE DISEASES |
Country Status (1)
Country | Link |
---|---|
CY (2) | CY1115965T1 (en) |
-
2015
- 2015-01-16 CY CY20151100047T patent/CY1115965T1/en unknown
-
2016
- 2016-03-08 CY CY20161100203T patent/CY1117505T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CY1115965T1 (en) | 2017-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008006076A (en) | Methods, compositions, and kits for the treatment of medical conditions. | |
CY1121408T1 (en) | PREVENTION AND TREATMENT OF CONCLUSION DISEASE AND STYLE DISEASE | |
CY1115617T1 (en) | USE OF PATIENTS IN TREATMENT OF DISEASES THAT ARE CONCERNED WITH THE PROTEIN TOWARDS WHICH INCLUDE THE DISEASE | |
DE602004028920D1 (en) | BY | |
EA200901211A1 (en) | ANTIGENS OF C5 PROTEIN AND THEIR APPLICATION | |
SG146653A1 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
UY29284A1 (en) | AB (BETA) HUMANIZED ANTIBODIES USED TO IMPROVE COGNITION | |
CR8095A (en) | HUMANIZED ANTIBODIES RECOGNIZING THE BETA AMILOIDEO BODY | |
WO2007103549A3 (en) | Complement binding aptamers and anti-c5 agents useful in the treatment of ocular disorders | |
NO20076241L (en) | Vascular disease therapies | |
EA200700427A1 (en) | PREVENTION AND TREATMENT OF SYNUCLEOPATHIC AND AMYLOIDOGENIC DISEASES | |
EA200400518A1 (en) | METHODS OF TREATING EYE NONASCULAR DISEASES | |
DK1814590T3 (en) | Treatment of obesity and related diseases | |
ATE502633T1 (en) | CYCLOSPORINS FOR THE TREATMENT AND PREVENTION OF EYE DISEASES | |
SG147442A1 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
MX2007010752A (en) | Ophthalmic uses of s1p receptor modulators. | |
CY1110182T1 (en) | IDEENONON FOR THE TREATMENT OF MUSCLE DYSTROPHY | |
DE602004023183D1 (en) | PHOTODYNAMIC THERAPY PROVIDED AGAINST ANTIBODIES | |
CR9200A (en) | USE OF A 5-HT6 AGONIST FOR THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS | |
MX2020009532A (en) | Modified oligonucleotides for use in treatment of tauopathies. | |
GB0606015D0 (en) | therapeutic agents | |
WO2006012521A3 (en) | Treatment for ocular disease | |
WO2008042314A3 (en) | Diagnosis and treatment of disorders of the eye | |
CY1117505T1 (en) | SUPPLEMENTARY BATTERY ADMINISTRATION AND FACTORS AGAINST CY C5 USEFUL IN EDUCATION AGAINST EYE DISEASES | |
EP1297849A4 (en) | Remedial agent for optic nerve disease and the like |